A multicenter, randomized, double-blind, placebo-parallel controlled clinical trial on the efficacy and safety of acupoint application of traditional Chinese medicine in children with COVID-19 (mild) fever

INTERVENTION: Experimental group:Chinese medicine paste;Control group:Chinese medicine patch with placebo; CONDITION: children novel coronavirus pneumonia (COVID‐19) (mild) PRIMARY OUTCOME: Time for complete remission of fever; SECONDARY OUTCOME: Antipyretic onset time;Emergency antipyretic drugs (acetaminophen) usage;Individual symptom score 3 and 5 days after treatment;Adverse drug reaction; INCLUSION CRITERIA: 1. Meet the diagnostic criteria for novel coronavirus pneumonia (mild) or be diagnosed with novel coronavirus pneumonia (mild); 2. Aged range from 3 to 14 years (inclusive); 3. Body temperature >=37.3? (the body temperature in the consulting room on the day of treatment and the highest body temperature within 2 hours shall be considered); 4. No more than 48 hours have passed since the first onset of symptoms (or confirmed onset of illness); 5. Agreed to participate in the study, and the children's families/children signed the informed consent.